Evidence map›Paper›PMID 26500350›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination.

Zhangguo Chen, Andrew Getahun, Xiaomi Chen, Yonatan Dollin, John C Cambier, Jing H Wang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. PI3K Isoforms in B Cells.Current topics in microbiology and immunology · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Targeting PI3K Signaling in Acute Lymphoblastic Leukemia.International journal of molecular sciences · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Zhangguo Chen *Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045.
Andrew Getahun *Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045.
Xiaomi ChenDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045.
Yonatan DollinDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045.
John C CambierDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045.
Jing H WangDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045.
National Jewish Health · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C · 1985 to 2011
$11.7M
Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
Infectious Agents and B Cell AnergyR01AI077597 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2010 to 2014
$1.9M
Mechanisms promoting translocations and mature B cell lymphomasR01CA166325 · NCI · UNIVERSITY OF COLORADO DENVER · PI WANG, JING HONG · 2012 to 2016
$1.7M
Role of Target DNA sequences in mutation and DNA Break GenerationR21AI110777 · NIAID · UNIVERSITY OF COLORADO DENVER · PI WANG, JING HONG · 2015 to 2016
$427k
Genomic instability mediated via differential DNA repair mechanisms in B cellsR21CA184707 · NCI · UNIVERSITY OF COLORADO DENVER · PI WANG, JING HONG · 2015 to 2016
$372k
NCI NIH HHS R01 CA166325NCI NIH HHS R01CA166325NCI NIH HHS R21 CA184707NCI NIH HHS R21CA184707NIAID NIH HHS P01 AI022295NIAID NIH HHS P01AI022295NIAID NIH HHS R01 AI077597NIAID NIH HHS R01AI077597NIAID NIH HHS R21 AI110777NIAID NIH HHS R21AI110777NIAID NIH HHS T32 AI074491
6 · The paper itself

Abstract

Class switch recombination (CSR) generates isotype-switched Abs with distinct effector functions. B cells express phosphatase and tensin homolog (PTEN) and multiple isoforms of class IA PI3K catalytic subunits, including p110α and p110δ, whose roles in CSR remain unknown or controversial. In this article, we demonstrate a direct effect of PTEN on CSR signaling by acute deletion of Pten specifically in mature B cells, thereby excluding the developmental impact of Pten deletion. We show that mature B cell-specific PTEN overexpression enhances CSR. More importantly, we establish a critical role for p110α in CSR. Furthermore, we identify a cooperative role for p110α and p110δ in suppressing CSR. Mechanistically, dysregulation of p110α or PTEN inversely affects activation-induced deaminase expression via modulating AKT activity. Thus, our study reveals that a signaling balance between PTEN and PI3K isoforms is essential to maintain normal CSR.

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesCells, CulturedClass I Phosphatidylinositol 3-KinasesCytidine DeaminaseImmunoglobulin Class SwitchingImmunoglobulin EImmunoglobulin GMiceMice, KnockoutProtein IsoformsProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseSignal Transduction1-phosphatidylinositol 3-kinase p110 subunit, mouseAICDA (Activation-Induced Cytidine Deaminase)Class I Phosphatidylinositol 3-KinasesCytidine DeaminaseImmunoglobulin EImmunoglobulin GProtein IsoformsProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePten protein, mouse

Identifiers

PMID26500350
PMCPMC4655169
OpenAlexW1827897568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.